Target intelligence / Profile preview

Beta-1,3-N-acetylgalactosaminyltransferase 2 pseudogene 1 (B3GALNT2P1)

Target
B3GALNT2P1
Molecular classification
Pseudogene
01

Overview

Beta-1,3-N-acetylgalactosaminyltransferase 2 pseudogene 1 is a human pseudogene, meaning it is a non-protein-coding DNA sequence similar to the functional B3GALNT2 gene but contains mutations that prevent it from encoding a functional protein. Pseudogenes arise through evolutionary gene duplication or retrotransposition and may retain some regulatory roles at the RNA level, such as acting as decoys for microRNAs or influencing the stability of transcripts for related genes. However, there is no evidence that B3GALNT2P1 encodes a functional protein or acts as a drug target, and there is no data linking it directly to disease states or therapeutic intervention.

02

Biological functions

Other (Potential regulatory functions only via RNA, not via protein function)
03

Disease associations

Other (Pseudogenes occasionally have regulatory effects in cancer and other diseases, but no evidence links B3GALNT2P1 specifically to disease)

Beyond the preview

Go deeper on Beta-1,3-N-acetylgalactosaminyltransferase 2 pseudogene 1 (B3GALNT2P1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Beta-1,3-N-acetylgalactosaminyltransferase 2 pseudogene 1 (B3GALNT2P1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call